azacitidine has been researched along with Autoimmune Disease in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 10 (58.82) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Itani, K; Kai, Y; Kohno, K; Kondo, Y; Matsumoto, M; Miura, G; Nakayama, T; Saburi, M; Soga, Y | 1 |
Dasanu, CA; Kaur, J; Tuler, S | 1 |
Aisa, Y; Fujita, Y; Ito, C; Masuda, K; Mori, T; Nakazato, T; Osada, Y | 1 |
Balog, A; Block, JA; Bukiej, AA; Glant, TT; Jolly, M; Kovács, L; Markovics, A; Mikecz, K; Ocskó, T; Rauch, TA; Ruthberg, AD; Tóth, DM; Vida, A | 1 |
Al Ustwani, O; Ambrus, J; Barcos, M; Block, AM; Ford, LA; Griffiths, EA; Sait, SJ; Thompson, JE; Vigil, CE; Wang, ES; Wetzler, M | 1 |
Fu, Y; Hu, Z; Kuang, N; Min, W; Shu, K; Zhang, Y; Zhang, Z | 1 |
Al Ali, NH; Bart-Smith, E; Craig, BM; Epling-Burnette, PK; Komrokji, RS; Kordasti, S; Kulasekararaj, A; Lancet, JE; List, AF; Mufti, GJ; Padron, E; Pinilla-Ibarz, J; Zhang, L | 1 |
Aouba, A; Arlet, JB; Berthier, S; Braun, T; Buchdahl, AL; Decaux, O; Denis, G; Fain, O; Fenaux, P; Fraison, JB; Gardin, C; Grignano, E; Kahn, JE; Leon, N; Liozon, E; Lortholary, O; Maigne, G; Mekinian, A; Omouri, M; Park, S; Rossignol, J | 1 |
Bottinger, EP; Bromberg, JS; Ding, Y; Ju, W; Lal, G; Levy, DE; Reid, SP; van der Touw, W; Zhang, N | 1 |
Al Ustwani, O; Ambrus, J; Francis, J; Wallace, PK; Wetzler, M | 1 |
Doleris, LM; Dreyfus, F; Park, S; Pilorge, S | 1 |
Bazanis, E; Benopoulou, O; Diamantopoulos, PT; Meletis, J; Michael, M; Tzeletas, G; Vayopoulos, G; Viniou, NA | 1 |
Richardson, B | 1 |
Erf, GF; Smyth, JR; Sreekumar, GP | 1 |
Ambady, S; Ponce de Leon, FA; Smyth, JR; Sreekumar, GP | 1 |
Izui, S; Merino, R; Shibata, T; Yoshida, H; Yoshida, M | 1 |
Csordas, A; Dietrich, H; Krömer, G; Schauenstein, K; Wick, G | 1 |
2 review(s) available for azacitidine and Autoimmune Disease
Article | Year |
---|---|
Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Prognosis; Treatment Outcome; Young Adult | 2013 |
DNA methylation and autoimmune disease.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Azacitidine; Cell Communication; DNA Methylation; Humans; Hydralazine; In Vitro Techniques; Lupus Erythematosus, Systemic; Models, Immunological; Procainamide; T-Lymphocytes | 2003 |
15 other study(ies) available for azacitidine and Autoimmune Disease
Article | Year |
---|---|
[Successful treatment of myelodysplastic syndrome-associated autoinflammatory lymphedema with azacytidine].
Topics: Aged, 80 and over; Autoimmune Diseases; Azacitidine; Female; Humans; Lymphedema; Myelodysplastic Syndromes; Pancytopenia | 2019 |
Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azacitidine; Female; Humans; Myelodysplastic Syndromes; Pancytopenia | 2021 |
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Topics: Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Azacitidine; Early Diagnosis; Factor V; Factor V Deficiency; Gingival Hemorrhage; Humans; Immunosuppressive Agents; Male; Partial Thromboplastin Time; Prednisone; Prothrombin Time | 2018 |
Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Azacitidine; B-Lymphocytes; Chromatin Immunoprecipitation; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Flow Cytometry; Gene Silencing; Mice | 2019 |
Therapeutic effect of daphnetin on the autoimmune arthritis through demethylation of proapoptotic genes in synovial cells.
Topics: Animals; Annexin A5; Apoptosis; Arthritis, Experimental; Autoimmune Diseases; Azacitidine; Cell Survival; DNA Methylation; Gene Expression Regulation; Necrosis; Propidium; Rats; Synovial Membrane; Umbelliferones | 2014 |
Autoimmune diseases and myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azacitidine; Comorbidity; Disease Progression; Disease Susceptibility; Female; Follow-Up Studies; Hashimoto Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Kaplan-Meier Estimate; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Prevalence; Proportional Hazards Models; Retrospective Studies; Thalidomide; Thyroiditis, Autoimmune; Young Adult | 2016 |
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azacitidine; Female; Humans; Inflammation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies | 2016 |
Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.
Topics: Animals; Autoimmune Diseases; Azacitidine; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Colitis; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Forkhead Transcription Factors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; T-Lymphocytes, Regulatory | 2009 |
Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cells.
Topics: Adult; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; Blood Cell Count; Down-Regulation; Humans; Huntington Disease; Lupus Erythematosus, Systemic; Male; Myelodysplastic Syndromes; T-Lymphocytes, Regulatory | 2011 |
The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases.
Topics: Aged; Autoimmune Diseases; Azacitidine; Humans; Immunologic Factors; Male; Middle Aged; Myelodysplastic Syndromes | 2011 |
Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.
Topics: Anti-Retroviral Agents; Antimetabolites, Antineoplastic; Autoimmune Diseases; Azacitidine; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Polymerase Chain Reaction; Treatment Outcome | 2012 |
5-azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo.
Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Chickens; Disease Models, Animal; Erythrocyte Count; Feathers; Incidence; Leukocyte Count; Lymphocyte Activation; Lymphoid Tissue; Organ Size; Vitiligo | 1996 |
Analysis of the effect of endogenous viral genes in the Smyth line chicken model for autoimmune vitiligo.
Topics: Animals; Autoimmune Diseases; Azacitidine; Blotting, Northern; Chickens; Deoxyribonuclease HindIII; Deoxyribonucleases, Type II Site-Specific; Disease Models, Animal; DNA; DNA Fingerprinting; DNA Methylation; Endogenous Retroviruses; Female; Fibroblasts; Genes, Viral; In Situ Hybridization, Fluorescence; Male; Pedigree; Polymorphism, Restriction Fragment Length; RNA Viruses; RNA, Viral; Vitiligo | 2000 |
5-Azacytidine inhibits the lpr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/MpJ-lpr/lpr mice.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azacitidine; Female; Immunoglobulin G; Immunosuppressive Agents; Lupus Nephritis; Lymphoproliferative Disorders; Mice; Mice, Inbred BALB C; Survival Rate; T-Lymphocytes | 1990 |
In-vivo treatment with 5-azacytidine causes degeneration of central lymphatic organs and induces autoimmune disease in the chicken.
Topics: Animals; Autoimmune Diseases; Azacitidine; Body Weight; Bone Marrow; Chickens; Lymphatic Diseases; Lymphoid Tissue; Organ Size; Organ Specificity | 1991 |